bendamustine hydrochloride has been researched along with maytansine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carrigan, CN; Chicklas, S; Chittenden, T; Deckert, J; Erickson, HK; Lai, KC; Lambert, JM; Li, M; Lutz, RJ; Mayo, MF; Park, PU; Pinkas, J; Yi, Y | 1 |
1 other study(ies) available for bendamustine hydrochloride and maytansine
Article | Year |
---|---|
A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; B-Lymphocytes; Bendamustine Hydrochloride; Cell Line, Tumor; Cyclophosphamide; Cytotoxicity, Immunologic; Drug Screening Assays, Antitumor; Female; Humans; Immunotoxins; Maytansine; Mice; Mice, SCID; Molecular Targeted Therapy; Nitrogen Mustard Compounds; Prednisone; Rituximab; Tetraspanins; Vincristine; Xenograft Model Antitumor Assays | 2013 |